Analyzing Black Titan (NASDAQ:BTTC) and Amdocs (NASDAQ:DOX)

Black Titan (NASDAQ:BTTCGet Free Report) and Amdocs (NASDAQ:DOXGet Free Report) are both technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Insider & Institutional Ownership

92.0% of Amdocs shares are owned by institutional investors. 53.7% of Black Titan shares are owned by company insiders. Comparatively, 15.4% of Amdocs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Black Titan has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.

Earnings & Valuation

This table compares Black Titan and Amdocs”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Black Titan $2.18 million 3.01 -$4.71 million ($2.95) -0.21
Amdocs $4.53 billion 1.47 $564.70 million $4.20 14.72

Amdocs has higher revenue and earnings than Black Titan. Black Titan is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Black Titan and Amdocs’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Black Titan N/A N/A N/A
Amdocs 9.75% 20.28% 10.94%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Black Titan and Amdocs, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Black Titan 1 0 0 0 1.00
Amdocs 1 3 3 0 2.29

Amdocs has a consensus target price of $86.67, suggesting a potential upside of 40.15%. Given Amdocs’ stronger consensus rating and higher possible upside, analysts clearly believe Amdocs is more favorable than Black Titan.

Summary

Amdocs beats Black Titan on 11 of the 14 factors compared between the two stocks.

About Black Titan

(Get Free Report)

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.

About Amdocs

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; end-to-end application development and maintenance services; and ongoing maintenance services. In addition, the company provides a line of services designed for various stages of a service provider’s lifecycle includes consulting, delivery, quality engineering, operations, systems integration, network services, experience-driven services, data, cloud, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, entertainment, and media industry service providers, as well as mobile virtual network operators. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.

Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.